Cargando…

Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders

Patients with moderate to severe immunosuppression, a condition that is common in many hematologic diseases because of the pathology itself or its treatment, are at high risk for COVID-19 and its complications. While empirical data are sometimes conflicting, this heightened risk has been confirmed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saade, Elie A., Hojat, Leila S., Gundelly, Praveen, Salata, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398935/
https://www.ncbi.nlm.nih.gov/pubmed/36494144
http://dx.doi.org/10.1016/j.beha.2022.101375